The raised full-year guidance and strong Q3 beat, particularly in the engineering segment, signal sustained demand momentum. Monitor Q4 execution against the 8%-10% growth guidance and any further updates on utilization and margin expansion.
Price Chart
Executive Summary
Exponent reported Q3 2026 revenue of $173.7M (up 18% YoY) and GAAP diluted EPS of $0.64 (up from $0.55), both above consensus estimates of $153.4M and $0.62. The company raised full-year guidance for revenue growth to 10%-11% (from prior high-single digits) and EBITDA margin to 28.0%-28.3%, reflecting strong year-to-date performance and demand across engineering and scientific segments.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $173.7M, up 18% YoY from $147.1M
- Q3 2026 GAAP diluted EPS $0.64, up from $0.55 YoY
- Revenue before reimbursements $153.1M, up 12% YoY
- EBITDA $45.0M, or 29.4% of revenues before reimbursements, up from 28.3%
- Full-year guidance raised: revenues before reimbursements growth 10%-11% (from high-single digits), EBITDA margin 28.0%-28.3%
- Q4 2026 guidance: revenues before reimbursements growth 8%-10%, EBITDA margin 26.3%-26.8%
- Engineering segment (85% of revenue) grew 13% YoY; environmental/health segment (15%) grew 3%
- Utilization rate 77% in Q3 2026
- Year-to-date cash returned: $46.1M dividends, $146.1M stock repurchases; cash balance $114.7M
Financial Impact
Revenue beat consensus by $20.3M (13.2%), EPS beat consensus by $0.02 (3.2%); guidance raised for full-year revenue and margin
Segment Breakdown
| Segment | Growth |
|---|---|
| Engineering and Other Scientific | +13.0% |
| Environmental and Health | +3.0% |
Risk Factors
- Guidance assumes continued demand; any slowdown in user research or dispute-related work could pressure results
- Reimbursements revenue ($20.7M) more than doubled YoY, adding volatility to total revenue comparisons
- Stock-based compensation rose to $6.7M in Q3 from $5.3M a year ago, a 25% increase
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3391839 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 8-K | $78.31 | awaiting T+1 | awaiting T+1 | $80.26 (+2.49%) |
Oct 29, 2026 3d ago | Press Release | No price | awaiting T+1 | awaiting T+1 | No price |
Oct 29, 2026 3d ago | Institutional Cluster | $78.31 $80.26 | ▼ −2.49% | ▼ −4.26% | $80.26 (−2.49%) |
Jul 9, 2026 16w ago | Press Release | $62.10 $63.59 | ▲ +2.40% | ▲ +3.17% | $80.26 (+29.24%) |
May 27, 2026 22w ago | Insider Cluster | $57.08 $58.42 | ▲ +2.35% | ▲ +1.80% | $80.26 (+40.61%) |
May 19, 2026 23w ago | Insider Cluster | $56.99 $58.23 | ▲ +2.18% | ▲ +1.14% | $80.26 (+40.83%) |
May 15, 2026 24w ago | Insider Cluster | $57.05 $56.69 | ▼ −0.63% | ▲ +0.02% | $80.26 (+40.68%) |
May 13, 2026 24w ago | Insider Cluster | $54.54 $53.67 | ▼ −1.60% | ▼ −2.37% | $80.26 (+47.16%) |
Apr 30, 2026 26w ago | 8-K | No price | awaiting T+1 | awaiting T+1 | No price |
Apr 30, 2026 26w ago | Press Release | $65.28 $64.96 | ▼ −0.49% | ▼ −0.15% | $80.26 (+22.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers